Skip to main content

Table 1 Characteristics of the study patients based on age group

From: Age-related differences in factors associated with the underuse of recommended medications in acute coronary syndrome patients at least one year after hospital discharge

 

Overall (n = 469)

65 years of age and older (n = 202)

Younger than 65 years of age (n = 267)

p

Age, years

62.4 ± 9.7

71 ± 5

56 ± 6.9

< 0.001

Gender, female, n (%)

142 (30.3)

67 (33.2)

75 (28.1)

0.264

Married

442 (94.2)

187 (92.6)

255 (95.5)

0.229

Educational level

    

 Junior high school or lower

166 (35.4)

91 (45.0)

75 (28.1)

< 0.001

 Senior high school

198 (42.2)

86 (42.6)

112 (41.9)

 

 University/college

105 (22.4)

25 (12.4)

80 (30.0)

 

Manual laborer

48 (10.2)

26 (12.9)

22 (8.2)

0.101

Employed

178 (38)

7 (3.5)

171 (64)

< 0.001

Income (Chinese yuan/month)

    

 1,200 - 3,000

248 (52.9)

156 (77.2)

92 (34.5)

< 0.001

 3,000 - 5,000

166 (35.4)

27 (13.4)

139 (52.1)

 

 ≥ 5,000

55 (11.7)

19 (9.4)

36 (13.5)

 

Basic medical insurance*

391 (83.4)

162 (80.2)

229 (85.8)

0.109

Live alone

29 (6.2)

20 (9.9)

9 (3.4)

0.004

Currently smoking

111 (23.7)

45 (22.3)

66 (24.7)

0.538

Regular alcohol use

30 (6.4)

12 (5.9)

18 (6.7)

0.726

Depressive symptoms (PHQ score)

4 (2–7)

4 (2–6)

5 (3–7)

0.005

No. of diseased vessels

1 (1–2)

1 (1–2)

1 (1–2)

0.107

Comorbidities

    

 Congestive heart failure

37 (7.9)

27 (13.4)

10 (3.7)

< 0.001

 Diabetes

103 (22.0)

57 (28.2)

46 (17.2)

0.004

 Hypertension

262 (55.9)

122 (60.4)

140 (52.4)

0.086

 Dyslipidemia

84 (17.9)

49 (24.3)

35 (13.1)

0.002

 Cardiac dysrhythmias

31 (6.6)

18 (8.9)

13 (4.9)

0.081

 Stroke

27 (5.8)

17 (8.4)

10 (3.7)

0.032

 Any previous revascularization

36 (7.7)

21 (10.4)

15 (5.6)

0.054

 Chronic renal failure

38 (8.1)

24 (11.9)

14 (5.2)

0.009

 COPD

29 (6.2)

19 (9.4)

10 (3.7)

0.012

 Gastrointestinal disease

48 (10.2)

27 (13.4)

21 (7.9)

0.052

 Others

45 (9.6)

29 (14.4)

16 (6.0)

0.002

In-hospital treatment (PCI/CABG)

444 (94.7)

190 (94.1)

254 (95.1)

0.609

Time between discharge and follow-up survey, months

19.5 ± 2.6

19.3 ± 2.6

19.7 ± 2.6

0.161

Number of outpatient cardiologist visits since hospital discharge

7 (5–9)

6 (4–8)

8 (6–10)

< 0.001

Rehospitalization since discharge#

0 (0–1)

0 (0–1)

0 (0–1)

0.092

Medication use at discharge

    

 Aspirin

445 (94.9)

188 (93.1)

257 (96.5)

0.121

 Beta-blocker

420 (89.6)

175 (86.6)

245 (91.8)

0.072

 Statin

414 (88.3)

172 (85.1)

242 (90.6)

0.067

 ACE inhibitor/ARB

319 (68.0)

135 (66.8)

184 (68.9)

0.632

Number of prescribed medications§

6 (5–10)

8 (5–12)

5 (4–7)

< 0.001

  1. Data are represented as the number (%) of patients; *medical insurance provided by the government; STEMI, ST segment elevated myocardial infarction; NSTEMI, non-ST segment elevated myocardial infarction; COPD, chronic obstructive pulmonary disease; CABG, coronary artery bypass graft; PCI, percutaneous coronary intervention; ACEI, angiotensin- converting enzyme; #patient was readmitted for a cardiac catheterization, PCI, stress test, or other causes during the interim follow-up period from hospital discharge to the date of the follow-up survey; ARB, angiotensin receptor blocker; §the number of patients using prescribed medications, including non-recommended medications.